Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype

Diabetologia

Volumn 49, Issue 6, 2006, Pages 1190-1197

  Flanagan, S E ^a   Edghill, E L ^a   Gloyn, A L ^a   Ellard, S ^a   Hattersley, A T ^a  

^a PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

ATP sensitive potassium channel; Diabetes; Genetics; KCNJ11; Kir6.2; Permanent neonatal diabetes; Sulfonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; INSULIN; SULFONYLUREA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL FEATURE; DEVELOPMENTAL DISORDER; DIABETES MELLITUS; EPILEPSY; FEMALE; GENE; GENE MUTATION; GENOTYPE; HUMAN; INFANT; KCNJ11 GENE; MAJOR CLINICAL STUDY; MALE; NEONATAL DIABETES SYNDROME; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; DIABETES MELLITUS; DNA PRIMERS; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MODELS, MOLECULAR; MUTATION; PHENOTYPE; POTASSIUM CHANNELS, INWARDLY RECTIFYING; PROTEIN CONFORMATION; WORLD HEALTH;

EID: 33646513278     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0246-z     Document Type: Article

References (25)

1. Gloyn AL, Pearson ER, Antcliff JF et al (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849
2. Gloyn AL, Reimann F, Girard C et al (2005) Relapsing diabetes can result from moderately activating mutations in KCNJ11. Hum Mol Genet 14:925-934
3. Yorifuji T, Nagashima K, Kurokawa K et al (2005) The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3174-3178
4. Massa O, Iafusco D, D'Amato E et al (2005) KCNJ11 activating mutations in Italian patients with permanent neonatal diabetes. Hum Mutat 25:22-127
5. Hattersley AT, Ashcroft FM (2005) Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 54:2503-2513
6. Sagen JV, Raeder H, Hathout E et al (2004) Permanent neonatal diabetes due to mutations in KCNJ11 encoding Kir6.2: patient characteristics and initial response to sulfonylurea therapy. Diabetes 53:2713-2718
7. Klupa T, Edghill EL, Nazim J et al (2005) The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of beta cell function among carriers of the R201H mutation. Diabetologia 48:1029-1031
8. Zung A, Glaser B, Nimri R, Zadik Z (2004) Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507
9. Codner E, Flanagan S, Ellard S, Garcia H, Hattersley AT (2005) High-dose glibenclamide can replace insulin therapy despite transitory diarrhea in early-onset diabetes caused by a novel R201L Kir6.2 mutation. Diabetes Care 28:758-759
10. Vaxillaire M, Populaire C, Busiah K et al (2004) Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients. Diabetes 53:2719-2722
11. Shield JPH (1996) Neonatal diabetes. In: Shield JPH, Baum JD (eds) Childhood diabetes. Bailliere Tindall, London, pp 681-740
12. Polak M, Shield J (2004) Neonatal and very-early-onset diabetes mellitus. Semin Neonatol 9:59-65
13. Edghill EL, Gloyn AL, Gillespie KM et al (2004) Activating mutations in the KCNJ11 gene encoding the ATP-sensitive K+ channel subunit Kir6.2 are rare in clinically defined type 1 diabetes diagnosed before 2 years. Diabetes 53:2998-3001
14. Proks P, Girard C, Haider S et al (2005) A gating mutation at the internal mouth of the Kir6.2 pore is associated with DEND syndrome. EMBO Rep 6:470-475
15. Gloyn AL, Cummings EA, Edghill EL et al (2004) Permanent neonatal diabetes due to paternal germline mosaicism for an activating mutation of the KCNJ11 gene encoding the Kir6.2 subunit of the beta-cell potassium adenosine triphosphate channel. J Clin Endocrinol Metab 89:3932-3935
16. Colombo C, Delvecchio M, Zecchino C, Faienza MF, Cavallo L, Barbetti F (2005) Transient neonatal diabetes mellitus is associated with a recurrent (R201H) KCNJ11 (KIR6.2) mutation. Diabetologia 48:2439-2441
17. Proks P, Antcliff JF, Lippiat J, Gloyn AL, Hattersley AT, Ashcroft FM (2004) Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features. Proc Natl Acad Sci USA 101:17539-17544
18. Antcliff JF, Haider S, Proks P, Sansom MS, Ashcroft FM (2005) Functional analysis of a structural model of the ATP-binding site of the KATP channel Kir6.2 subunit. EMBO J 24:229-239
19. Gloyn AL, Diatloff-Zito C, Edghill EL et al (2006) Extra-pancreatic manifestations of KCNJ11 activating mutations: evidence to support a discrete syndrome of developmental delay, epilepsy and neonatal diabetes (DEND). Eur J Hum Genet (in press)
20. Haider S, Antcliff JF, Proks P, Sansom MS, Ashcroft FM (2005) Focus on Kir6.2: a key component of the ATP-sensitive potassium channel. J Mol Cell Cardiol 38:927-936
21. Tucker SJ, Gribble FM, Proks P et al (1998) Molecular determinants of KATP channel inhibition by ATP. EMBO J 17:3290-3296
22. Iafusco D, Stazi MA, Cotichini R et al (2002) Permanent diabetes mellitus in the first year of life. Diabetologia 45:798-804
23. Proks P, Girard C, Ashcroft FM (2005) Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP. Hum Mol Genet 14:2717-2726
24. Cole TJ, Freeman JV, Preece MA (1998) British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood. Stat Med 17:407-429
25. Kuo A, Antcliff JF, Rahman T (2003) Crystal structure of the potassium channel KirBac 1.1 in the closed state. Science 300:1922-1926